ROCKVILLE, Md., Aug. 3, 2023 /PRNewswire/ -- Shuttle Pharmaceuticals Holdings, Inc. (SHPH), a discovery and development stage specialty pharmaceutical company focused on improving the outcomes of ...

Global High Potency API CDMOs Market OverviewThe global High Potency API CDMOs market is projected to achieve strong single-digit growth by 2027, driven by a rapid surge in demand for oncology ...

Clinical Trials in Cancer Cachexia, Inflammatory Bowel Disease and Retinal Disorders are Planned MONTVALE, N. J., Jan. 07, 2026 (GLOBE ...

The move would dismantle the existing system under which bulk drugs and finished formulations operate under a common licence ...

Big pharmaceutical companies are boosting their production capacity of branded medications with billions of dollars in new U.S. manufacturing plant construction, but generic drug production still ...

Proposal aims to build a database of bulk drug traders, improve traceability of imported raw materials, over 70% of which ...

In the fast-paced world of drug development, time is often the most precious commodity. For biotech companies working on oral ...

The dependency on Asia grows to supply its pharmaceutical industry and ensure the provision of essential medicines. Among the ...

It could be years before a cell therapy from Nkarta reaches autoimmune disease patients in the market, but CEO Paul Hastings still thinks about the impact of pharmaceutical tariffs here and now. With ...

President Donald Trump said Sept. 25 that he would enact a 100% pharmaceutical tariff starting Oct. 1 for brand-name and patented pharmaceuticals. Products manufactured by companies who are building a ...

WASHINGTON, DC - APRIL 2: President Donald Trump signs an executive order imposing tariffs on imported goods during a "Make America Wealthy Again" trade announcement event in the Rose Garden at the ...

Mapi Pharma Ltd., a fully integrated, late-stage clinical development biopharmaceutical company focused on introducing ...